Advertisement

Nutritional Supplements with Oral Amino Acid Mixtures Increases Whole-Body Lean Mass and Insulin Sensitivity in Elderly Subjects with Sarcopenia

      Decreases in whole-body lean mass can cause sarcopenia, a disease frequently found in the elderly. This condition is frequently associated with frailty and disability in aging as well as the onset and progression of several geriatric syndromes. Sarcopenia therefore must be managed with multidimensional approaches that include physical training, nutritional support, and metabolic and anabolic treatment. The purpose of our study was to assess the effect of an orally administered special mixture of amino acids (AAs) in elderly subjects with reduced lean body mass and sarcopenia. A randomized, open-label, crossover study was conducted in 41 elderly subjects (age range: 66–84 years) with sarcopenia, assigned to 2 distinct treatments (AAs and placebo). All subjects had normal body weight (body mass index within 19–23). The AA treatment consisted of 70.6 kcal/day (1 kcal = 4.2 kJ) of 8 g of essential AA snacks, given at 10:00 am and 5:00 pm. Lean mass was measured with dual-energy x-ray absorptiometry in leg, arm, and trunk tissues. Significant increases in whole-body lean mass in all areas were seen after 6 months and more consistently after 18 months of oral nutritional supplementation with AAs. Fasting blood glucose, serum insulin, and homeostatic model assessment of insulin resistance (an index of insulin resistance) significantly decreased during AA treatment. Furthermore, a significant reduction in serum tumor necrosis factor–α (TNF-α) and a significant increase in both insulin-like growth factor–1 (IGF-1) serum concentrations and in the IGF-1/TNF-α ratio were also found. No significant adverse effects were observed during AA treatment. These preliminary data indicate that nutritional supplements with the oral AA mixture significantly increased whole-body lean mass in elderly subjects with sarcopenia. The improvement in the amount of whole-body lean mass could be linked to increased insulin sensitivity and anabolic conditions related to IGF-1 availability.
      To read this article in full you will need to make a payment

      References

        • Roubenoff R.
        Sarcopenia: a major modifiable cause of frailty in the elderly.
        J Nutr Health Aging. 2000; 4: 140-142
        • Morley J.E.
        • Baumgartner R.N.
        • Roubenoff R.
        • Mayer J.
        • Nair K.S.
        Sarcopenia.
        J Lab Clin Med. 2001; 137: 231-243
        • Schrager M.
        • Bandinelli S.
        • Maggi S.
        • Ferrucci L.
        Sarcopenia: twenty open questions for a research agenda.
        Basic Appl Myol. 2003; 13: 203-208
        • Doherty T.J.
        Invited review: Aging and sarcopenia.
        J Appl Physiol. 2003; 95: 1717-1727
        • Kamel H.K.
        Sarcopenia and aging.
        Nutr Rev. 2003; 61: 157-167
        • Proctor D.N.
        • Balagopal P.
        • Nair K.S.
        Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins.
        J Nutr. 1998; 128: 351S-355S
        • Rudman D.
        • Feller A.G.
        • Cohn L.
        • Shetty K.R.
        • Rudman I.W.
        • Draper M.W.
        Effects of human growth hormone on body composition in elderly men.
        Horm Res. 1991; 36: 73-81
        • Nair K.S.
        Muscle protein turnover: methodological issues and the effects of aging.
        J Gerontol. 1995; 50: 107-114
        • Lexell J.
        • Taylor C.C.
        • Sjostrom M.
        What is the cause of the aging atrophy?.
        J Neuro Sci. 1988; 84: 275-295
        • Parise G.
        • Yarasheski K.E.
        The utility of resistance exercise training and amino acid supplementation for reversing age-associated decrements in muscle protein mass and function.
        Curr Opin Clin Nutr Metab Care. 2000; 3: 1489-1495
        • Roubenoff R.
        Origins and clinical relevance of sarcopenia.
        Can J Appl Physiol. 2001; 26: 78-89
        • Barrett E.J.
        • Schwartz R.G.
        • Young L.H.
        • Jacob R.
        • Zaret B.L.
        Effect of chronic diabetes on mitochondrial fuel metabolism and insulin sensitivity.
        Diabetes. 1988; 37: 943-948
        • Wolfe R.R.
        Effects of amino acid intake on anabolic processes.
        J Appl Physiol. 2001; 26: S220-S227
        • Volpi E.
        • Ferrando A.A.
        • Yeckel C.W.
        • Tipton K.D.
        • Wolfe R.R.
        Exogenous amino acid stimulates net muscle protein synthesis in the elderly.
        J Clin Invest. 1998; 101: 200-207
        • Nakajima Y.
        • Takamata A.
        • Matsukawa T.
        • Sessler D.I.
        • Kitamura Y.
        • Ueno H.
        • Tanaka Y.
        • Mizobe T.
        Effect of amino acid infusion on central thermoregulatory control in humans.
        Anesthesiology. 2004; 100: 634-639
        • Paddon-Jones D.
        • Sheffield-Moore M.
        • Zhang X.-J.
        • Volpi E.
        • Wolf S.E.
        • Asle A.
        • Ferrando A.A.
        • Wolfe R.R.
        Amino acid ingestion improves muscle protein synthesis in the young and elderly.
        Am J Physiol Endocrinol Metab. 2004; 286: E321-E328
        • Rasmussen B.B.
        • Wolfe R.R.
        • Volpi E.
        Oral and intravenously administered amino acids produce similar effects on muscle protein synthesis in the elderly.
        J Nutr Health Aging. 2002; 6: 358-362
        • Tipton K.D.
        • Ferrando A.A.
        • Phillips S.M.
        • Doyle Jr, D.
        • Wolfe R.R.
        Post exercise net protein synthesis in human muscle from orally administered amino acids.
        Am J Physiol Endocrinol Metab. 1999; 276: E628-E634
        • Tipton K.D.
        Muscle protein metabolism in the elderly: influence of exercise and nutrition.
        Can J Appl Physiol. 2001; 26: 588-606
        • Solerte S.B.
        • Fioravanti M.
        • Severgnini S.
        • Locatelli M.
        • Renzullo M.
        • Pezza N.
        • Cerutti N.
        • Ferrari E.
        Enhanced cytotoxic response of natural killer cells to interleukin-2 in Alzheimer's disease.
        Dementia. 1996; 7: 343-348
        • Solerte S.B.
        • Fioravanti M.
        • Vignati G.
        • Giustina A.
        • Cravello L.
        • Ferrari E.
        Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I.
        J Clin Endocrinol Metab. 1999; 84: 3260-3267
        • Solerte S.B.
        • Cravello L.
        • Ferrari E.
        • Fioravanti M.
        Overproduction of IFN-γ and TNF-α from natural killer cells (NK) is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease.
        Ann N Y Acad Sci USA. 2000; 917: 331-340
        • Solerte S.B.
        • Precerutti S.
        • Gazzaruso C.
        • Locatelli E.
        • Zamboni M.
        • Schifino N.
        • Bonacasa R.
        • Rondanelli M.
        • Taccani D.
        • Ferrari E.
        • Fioravanti M.
        Defect of a subpopulation of natural killer immune cells in Grave's disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
        Eur J Endocrinol. 2005; 152: 703-712
        • Doehner W.
        • Schoene N.
        • Rauchhaus M.
        • Leyva-Leon F.
        • Pavitt D.V.
        • Reaveley D.A.
        • Shuler G.
        • Coats A.J.
        • Anker S.D.
        • Hanbrecht R.
        Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
        Circulation. 2002; 105: 2619-2624
        • Pedersen B.K.
        • Ostrowski K.
        • Rohde T.
        • Bruunsgaard H.
        The cytokine response to strenuous exercise.
        Can J Physiol Pharmacol. 1998; 76: 505-511
        • Tsujinaka T.
        • Fujita J.
        • Ebisui C.
        • Yano M.
        • Kominami E.
        • Suzuki K.
        • Tanaka K.
        • Katsume A.
        • Ohsugi Y.
        • Shiozaki H.
        • Monden M.
        Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.
        J Clin Invest. 1996; 97: 244-249
        • Visser M.
        • Pahor M.
        • Taaffe D.R.
        • Goodpaster B.H.
        • Simonsik E.M.
        • Newman A.B.
        • Nevitt M.
        • Harris T.B.
        Relationship of interleukin 6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the Health ABC Study.
        J Gerontol A Biol Sci Med Sci. 2002; 57: M326-M332
        • Ji L.L.
        Exercise at old age: does it increase or alleviate oxidative stress?.
        Ann N Y Acad Sci. 2001; 928: 236-247
        • Volpi E.
        • Mittendorfer B.
        • Wolf S.E.
        • Wolfe R.R.
        Oral amino acids stimulate muscle protein anabolism in the elderly despite higher first-pass splanchnic extraction.
        Am J Physiol Clin Endocrinol Metab. 1999; 277: E513-E520
        • Volpi E.
        • Mittendorfer B.
        • Rasmussen B.B.
        • Wolfe R.R.
        The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly.
        J Clin Endocrinol Metab. 2000; 85: 4481-4490
        • Volpi E.
        • Kobayashi H.
        • Sheffield-Moore M.
        • Mittendorfer B.
        • Wolfe R.R.
        Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults.
        Am J Clin Nutr. 2003; 78: 250-258
        • Rasmussen B.B.
        • Tipton K.D.
        • Miller S.L.
        • Wolf S.E.
        • Wolfe R.R.
        An oral essential amino acid-carbohydrate supplement enhances muscle protein anabolism after resistance exercise.
        Am J Physiol. 2000; 88: 386-392
        • Traxinger R.R.
        • Marshall S.
        Role of amino acids in modulating glucose-induced desensitization of the glucose transport system.
        J Biol Chem. 1989; 264: 20910-20916
        • Solerte S.B.
        • Gazzaruso C.
        • Schifino N.
        • Locatelli E.
        • Destro T.
        • Ceresini G.
        • Ferrari E.
        • Fioravanti M.
        Metabolic effects of orally administered amino acid mixture in elderly subjects with poorly controlled type 2 diabetes mellitus.
        Am J Cardiol. 2004; 93: 23A-29A
        • Sulochana K.N.
        • Punithan R.
        • Ramakrishnan S.
        Beneficial effect of lysine and amino acids on cataractogenesis in experimental diabetes through possible antiglycation of lens proteins.
        Exp Eye Res. 1998; 67: 597-601